Baidu
map

Benef Microbes:芦荟乳杆菌辅助治疗吸烟者牙周炎的作用

2020-06-17 网络 网络

本随机临床试验旨在评价芦丁乳杆菌咀嚼片辅助非手术治疗吸烟患者慢性牙周炎的效果。

本随机临床试验旨在评价芦丁乳杆菌咀嚼片辅助非手术治疗吸烟患者慢性牙周炎的效果。

 

选取34名患者烟民,随机分为两组。SRP组(n=17)接受洗牙和根部刨除(SRP)一个疗程和安慰剂;PRO组(n=17)接受SRP一个疗程和2片益生菌片,每天2×,共21天。在基线和90天探诊出血(BOP)、探诊深度(PD)、临床附着水平(CAL)、牙龈退缩(GR)和PD≥5mm且出血量的牙袋。

 

结果显示,治疗90天后,两组PD及PD≥5mm的口袋及出血量较基线明显减少(P<0.05)。在PRO组中,与基线相比,90天时BOP有显著降低(P<0.05)。在基线和90天之间,PRO组深袋的PD减少有统计学意义(P<0.05)。各组在中、探诊PD的减少(P=0.95)和CAL的增益(P=0.97)上无统计学差异。

 

总之,在慢性牙周炎的治疗中,辅助使用L.reuteri在控制牙龈炎症方面是有效的,因为减少了探诊出血量,也就是减少了牙龈炎症,并且有效地减少了深袋,方式与临床相关。

 

原始出处:

 

L H Theodoro, M M Cláudio, et al., Effects of Lactobacillus reuteri as an Adjunct to the Treatment of Periodontitis in Smokers: Randomised Clinical Trial. Benef Microbes. 2019 Apr 19;10(4):375-384. doi: 10.3920/BM2018.0150.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1857890, encodeId=cdfa185e890f7, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Wed Oct 21 15:08:47 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2025323, encodeId=0c16202532363, content=<a href='/topic/show?id=6c8323646a0' target=_blank style='color:#2F92EE;'>#乳杆菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23646, encryptionId=6c8323646a0, topicName=乳杆菌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce68183, createdName=xiongke010, createdTime=Sat Aug 29 07:08:47 CST 2020, time=2020-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2084593, encodeId=65fe208459395, content=<a href='/topic/show?id=61f411e013b' target=_blank style='color:#2F92EE;'>#Micro#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11701, encryptionId=61f411e013b, topicName=Micro)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Tue Aug 11 06:08:47 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1451282, encodeId=2ef21451282e3, content=<a href='/topic/show?id=f0476e49582' target=_blank style='color:#2F92EE;'>#牙周#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67495, encryptionId=f0476e49582, topicName=牙周)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Fri Jun 19 05:08:47 CST 2020, time=2020-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605142, encodeId=b04e1605142c0, content=<a href='/topic/show?id=5cba39435fd' target=_blank style='color:#2F92EE;'>#吸烟者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39435, encryptionId=5cba39435fd, topicName=吸烟者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc8619318136, createdName=124984e7m89暂无昵称, createdTime=Fri Jun 19 05:08:47 CST 2020, time=2020-06-19, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1857890, encodeId=cdfa185e890f7, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Wed Oct 21 15:08:47 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2025323, encodeId=0c16202532363, content=<a href='/topic/show?id=6c8323646a0' target=_blank style='color:#2F92EE;'>#乳杆菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23646, encryptionId=6c8323646a0, topicName=乳杆菌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce68183, createdName=xiongke010, createdTime=Sat Aug 29 07:08:47 CST 2020, time=2020-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2084593, encodeId=65fe208459395, content=<a href='/topic/show?id=61f411e013b' target=_blank style='color:#2F92EE;'>#Micro#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11701, encryptionId=61f411e013b, topicName=Micro)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Tue Aug 11 06:08:47 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1451282, encodeId=2ef21451282e3, content=<a href='/topic/show?id=f0476e49582' target=_blank style='color:#2F92EE;'>#牙周#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67495, encryptionId=f0476e49582, topicName=牙周)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Fri Jun 19 05:08:47 CST 2020, time=2020-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605142, encodeId=b04e1605142c0, content=<a href='/topic/show?id=5cba39435fd' target=_blank style='color:#2F92EE;'>#吸烟者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39435, encryptionId=5cba39435fd, topicName=吸烟者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc8619318136, createdName=124984e7m89暂无昵称, createdTime=Fri Jun 19 05:08:47 CST 2020, time=2020-06-19, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1857890, encodeId=cdfa185e890f7, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Wed Oct 21 15:08:47 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2025323, encodeId=0c16202532363, content=<a href='/topic/show?id=6c8323646a0' target=_blank style='color:#2F92EE;'>#乳杆菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23646, encryptionId=6c8323646a0, topicName=乳杆菌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce68183, createdName=xiongke010, createdTime=Sat Aug 29 07:08:47 CST 2020, time=2020-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2084593, encodeId=65fe208459395, content=<a href='/topic/show?id=61f411e013b' target=_blank style='color:#2F92EE;'>#Micro#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11701, encryptionId=61f411e013b, topicName=Micro)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Tue Aug 11 06:08:47 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1451282, encodeId=2ef21451282e3, content=<a href='/topic/show?id=f0476e49582' target=_blank style='color:#2F92EE;'>#牙周#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67495, encryptionId=f0476e49582, topicName=牙周)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Fri Jun 19 05:08:47 CST 2020, time=2020-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605142, encodeId=b04e1605142c0, content=<a href='/topic/show?id=5cba39435fd' target=_blank style='color:#2F92EE;'>#吸烟者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39435, encryptionId=5cba39435fd, topicName=吸烟者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc8619318136, createdName=124984e7m89暂无昵称, createdTime=Fri Jun 19 05:08:47 CST 2020, time=2020-06-19, status=1, ipAttribution=)]
    2020-08-11 xjy02
  4. [GetPortalCommentsPageByObjectIdResponse(id=1857890, encodeId=cdfa185e890f7, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Wed Oct 21 15:08:47 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2025323, encodeId=0c16202532363, content=<a href='/topic/show?id=6c8323646a0' target=_blank style='color:#2F92EE;'>#乳杆菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23646, encryptionId=6c8323646a0, topicName=乳杆菌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce68183, createdName=xiongke010, createdTime=Sat Aug 29 07:08:47 CST 2020, time=2020-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2084593, encodeId=65fe208459395, content=<a href='/topic/show?id=61f411e013b' target=_blank style='color:#2F92EE;'>#Micro#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11701, encryptionId=61f411e013b, topicName=Micro)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Tue Aug 11 06:08:47 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1451282, encodeId=2ef21451282e3, content=<a href='/topic/show?id=f0476e49582' target=_blank style='color:#2F92EE;'>#牙周#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67495, encryptionId=f0476e49582, topicName=牙周)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Fri Jun 19 05:08:47 CST 2020, time=2020-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605142, encodeId=b04e1605142c0, content=<a href='/topic/show?id=5cba39435fd' target=_blank style='color:#2F92EE;'>#吸烟者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39435, encryptionId=5cba39435fd, topicName=吸烟者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc8619318136, createdName=124984e7m89暂无昵称, createdTime=Fri Jun 19 05:08:47 CST 2020, time=2020-06-19, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1857890, encodeId=cdfa185e890f7, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Wed Oct 21 15:08:47 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2025323, encodeId=0c16202532363, content=<a href='/topic/show?id=6c8323646a0' target=_blank style='color:#2F92EE;'>#乳杆菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23646, encryptionId=6c8323646a0, topicName=乳杆菌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce68183, createdName=xiongke010, createdTime=Sat Aug 29 07:08:47 CST 2020, time=2020-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2084593, encodeId=65fe208459395, content=<a href='/topic/show?id=61f411e013b' target=_blank style='color:#2F92EE;'>#Micro#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11701, encryptionId=61f411e013b, topicName=Micro)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Tue Aug 11 06:08:47 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1451282, encodeId=2ef21451282e3, content=<a href='/topic/show?id=f0476e49582' target=_blank style='color:#2F92EE;'>#牙周#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67495, encryptionId=f0476e49582, topicName=牙周)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Fri Jun 19 05:08:47 CST 2020, time=2020-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605142, encodeId=b04e1605142c0, content=<a href='/topic/show?id=5cba39435fd' target=_blank style='color:#2F92EE;'>#吸烟者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39435, encryptionId=5cba39435fd, topicName=吸烟者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc8619318136, createdName=124984e7m89暂无昵称, createdTime=Fri Jun 19 05:08:47 CST 2020, time=2020-06-19, status=1, ipAttribution=)]

相关资讯

J Peiodontal Res: FOXP3+和CD25+细胞在IV-C型牙周炎患者中减少

一些研究提出,调节性T细胞(Tregs)对炎症性骨吸收具有抑制作用。本研究旨在评估牙周炎患者炎症组织中的Treg免疫标志物。

所有心血管病人都该看牙科!欧洲牙周病学联盟与世界心脏联盟共识

口腔不健康,心脏也跟着受累。近期,欧洲牙周病学联盟(EFP)与世界心脏联盟(WHF)联合发布了牙周病和心血管病的专家共识。

Am J Dent:乳酸菌治疗严重牙周炎和口臭的临床效果

本研究旨在评价乳酸菌与重症牙周炎辅助治疗效果、牙周参数、口臭的临床关联。

J Peiodontal Res:褪黑素辅助治疗重度牙周炎

褪黑素具有抗炎,抗氧化和免疫调节能力,可能可以用于治疗牙周炎。本实验旨在评估在未接受治疗的重度牙周炎患者中,非手术牙周治疗(NSPT)后口服褪黑素是否比单独NSPT的治疗效果好。

J Clin Periodontol:IL-35通过调节Th17/Treg平衡抑制牙周炎小鼠的牙槽骨吸收水平

T淋巴细胞在牙周炎的发病过程中起着核心作用,辅助型T细胞17型(Th17)和调节型T细胞(Treg)的失衡在牙槽骨吸收起着决定性的作用。

J Peiodontal Res:黄芩素通过Nrf2抗氧化信号通路在治疗糖尿病实验性牙周炎中的作用

氧化应激已被认为是糖尿病慢性牙周炎(CPDM)的一个重要致病因素,而核因子相关因子2(Nrf2)在细胞防御氧化应激中发挥着重要作用。有研究提出黄芩素(BCI)在氧化应激相关疾病中的潜在治疗特性。

Baidu
map
Baidu
map
Baidu
map